Chronic non-bacterial osteomyelitis and immune checkpoint molecules

被引:0
作者
Ummusen Kaya Akca
Erdal Sag
Busra Aydın
Nur Kubra Tasdemir
Muserref Kasap Cuceoglu
Ozge Basaran
Ezgi Deniz Batu
Yelda Bilginer
Seza Ozen
机构
[1] Hacettepe University,Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine
[2] Sihhiye Campus,Translational Medicine Laboratories, Pediatric Rheumatology Unit
[3] Hacettepe University,undefined
关键词
Checkpoint molecules; Chronic non-bacterial osteomyelitis; PD-1; TIM-3;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:553 / 560
页数:7
相关论文
共 122 条
[1]  
Giedion A(1972)Subacute and chronic “symmetrical” osteomyelitis Ann Radiol 15 329-342
[2]  
Holthusen W(2007)Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients Rheumatology 46 154-160
[3]  
Masel L(2012)Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression Clin Immunol 145 69-76
[4]  
Vischer D(2011)Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression Clin Immunol 141 317-327
[5]  
Jansson A(2017)Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment Curr Osteoporos Rep 15 542-554
[6]  
Renner E(2015)Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release Clinical immunology 161 300-307
[7]  
Ramser J(2016)Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies J Rheumatol 43 1956-1964
[8]  
Hofmann SR(2021)Immune checkpoints, a novel class of therapeutic targets for autoimmune diseases Front Immunol 12 645699-1711
[9]  
Morbach H(2010)Lower expression levels of the programmed death 1 receptor on CD4+ CD25+ T cells and correlation with the PD-1.3 A genotype in patients with systemic lupus erythematosus Arthritis Rheum 62 1702-1880
[10]  
Schwarz T(2010)The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis Arthritis Rheum 62 1870-957